Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WARNER-LAMBERT's SALE OF IMED TO HENLEY GROUP COMPLETES DIVESTITURE

Executive Summary

WARNER-LAMBERT's SALE OF IMED TO HENLEY GROUP COMPLETES DIVESTITURE of the firm's health technologies businesses. W-L's board approved the sale for a cash price of $163.5 mil., the company announced April 25, adding that a definitive agreement has been signed by both companies. IMED posted sales "in excess of $100 mil." in 1985, according to W-L. Henley, which recently filed a registration statement with the Securities and Exchange Commission, was conceived late last year as an independent company to own and operate a number of businesses being divested by Allied-Signal, including Fisher Scientific and Instrumentation Labs. Excluding IMED, Henley has assets of approximately $4 bil. and annual sales in excess of $3 bil. In addition to Fisher and Instrumentation Labs, the Henley Group consists of "Allied industrial chemical companies, former engineering-related Signal companies, and some smaller manufacturing companies that have been in the family of Allied or Signal," the spokesman said. Warner-Lambert took about eight months to divest its health technologies businesses. Last August, the company sold its clinical lab diagnostics business to Akzo. In March, the company announced the sale of Deseret to Becton Dickinson ("The Pink Sheet" March 10, In Brief) and the sale of Reichert Instruments to Cambridge Instrument Company PLC of England.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS010070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel